4//SEC Filing
Glickman Mark A 4
Accession 0001179110-20-000171
CIK 0001434868other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:27 PM ET
Size
6.8 KB
Accession
0001179110-20-000171
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-01-02+5,925→ 25,925 total - Award
Stock Option (right to buy
2020-01-02+26,625→ 26,625 totalExercise: $61.34Exp: 2030-01-02→ Common Stock (26,625 underlying)
Footnotes (1)
- [F1]The award will vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2020.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001441461
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:27 PM ET
- Size
- 6.8 KB